| Literature DB >> 35552550 |
Rahel Vollenweider1, Anastasios I Manettas1, Nathalie Häni1, Eling D de Bruin2,3,4, Ruud H Knols2,5.
Abstract
Early mobilization, which includes active / passive motion in bed along with mobilization out of bed, is recommended to prevent the development of intensive care unit acquired-weakness (ICU-AW) for patients with critical illness on the intensive care unit. To date, the impact of passive motion of the lower extremities in sedated and ventilated patients remains unclear. The aim of the study is to systematically review and summarize the currently available randomized controlled trials in English or German language on the impact of passive motion of the lower extremities in sedated and ventilated patients ≥ 18 years in the intensive care unit on musculature, inflammation and immune system and the development of intensive care unit-acquired weakness and to evaluate the replicability of interventions and the methodological quality of included studies. A systematic literature search was performed up to 20th February 2022 in the databases Medline, Embase, Cochrane Library, CINAHL and PEDro. The description of the intervention (TIDieR checklist) and the methodological quality (Downs and Black checklist) were assessed. Five studies were included in the qualitative syntheses. On average, the studies were rated with 6.8 out of 12 points according to the TIDieR checklist. For the methodological quality an average of 19.8 out of 27 points on the Downs and Black checklist was reported. The results of included studies indicated that muscle loss may be reduced by passive manual movement, passive cycling and passive motion on a continuous passive motion-unit. In addition, positive effects were reported on the reduction of nitrosative stress and the immune response. The impact on the development of ICU-AW remains unclear. In conclusion, passive movement show a slight tendency for beneficial changes on cellular level in sedated and ventilated patients in the ICU within the first days of admission, which may indicate a reduction of muscle wasting and could prevent the development of ICU-AW. Future randomized controlled trials should use larger samples, use complete intervention description, use a comparable set of outcome measures, use rigorous methodology and examine the effect of passive motion on the development of ICU-AW.Entities:
Mesh:
Year: 2022 PMID: 35552550 PMCID: PMC9098053 DOI: 10.1371/journal.pone.0267255
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Search strategy.
| Description | MeSH-Terms | Free Text Words | |
|---|---|---|---|
|
| Ventilated and sedated critically ill patients in the intensive care unit | • Critical illness | • Critically ill |
|
| Passive motion of the lower extremities manually or by a therapy device | • Motion therapy, continuous passive | • Early passive exerc* / cycl* / mobili* / motion / «range of motion» / therap* / treat* / train* |
|
| no therapy, standard therapy or other dosage of the measure | - | - |
|
| Musculature | • Muscle strength / physiology | • Outcome |
|
| RCT | Randomized Controlled Trials |
- |
Presentation of the search terms for the literature search following the PICOS scheme [34].
Legend: MeSh-Terms = Medical Subject Headings, RCT = randomized controlled trial.
Fig 1Flow chart.
Presentation of the study selection process [33].
Characteristics of included studies.
| Reference | Design | Population | Setting | Intervention | Control | Outcome | Results |
|---|---|---|---|---|---|---|---|
|
| Within-patient randomized trial | No. = 20 | Two ICU in a reference hospital in Belém (Brasil) | Application of a cuff in the proximal part of one leg to restrict blood flow with a pressure value of 80% of the pat.’s systolic blood pressure in the anterior tibial artery. | Passive motion without the cuff during the ICU stay, 1x/day, 3x15 repetitions F/E in the knee joint with 2s duration for flexion and extension. | Muscle circumference and thickness (measured with ultrasound) of the quadriceps femoris muscle before the start of the intervention and after the end of the intervention without sedation and with the presence of volitional motor function. | The intervention was performed 11 ± 2.2 days. Muscle circumference and thickness were significantly reduced in both the intervention and control groups (p = 0.001). However, application of a cuff to the upper leg with passive exercise resulted in a 6.5% lower muscle loss (p = 0.001) compared to passive exercise alone (muscle circumference I: |
|
| Controlled randomized open clinical trial | No. = 19 | 16 bed ICU in the Agamenon Magalhães Hospital (Brasil) | Passive bed cycling of the lower extremities during 20min at a speed of 30 revolutions/min, single performance of the intervention. | No intervention | Analysis of nitrosative stress by determination of nitric oxide (NO) production in monocytes and determination of inflammatory cytokines (IL-6, IL-10, TNF-α, IFN-y) | 1 h after the intervention, there was a significantly reduced nitric oxide concentration (NO (C+), NO (CO-)) in the blood of the intervention group (p < 0.001). TNF-α was also significantly reduced by the intervention (p = 0.049). |
|
| Within-patient randomized clinical trial | no. = 5 | ICU at Whiston Hospital in Prescot (United Kingdom) | Passive movement in the ankle joint of one leg in PF/DE on a Straumann splint (CPM splint) during 7 days, 3x daily for 3h. | Standard therapy of the other leg with 2x/day < 5min passive stretching of the lower extremities by a PT | Percutaneous muscle biopsy of the anterior tibialis muscle on both sides for analysis of muscle tissue immediately before and at the end of the intervention after 7 days: | The intervention showed significant changes only in the more severely ill patients (APACHE II score > 19). Intervention in addition to standard therapy significantly reduced muscle fiber atrophy in severely ill patents (no. = 3, p = 0.025) compared to standard therapy alone. Type I muscle fibers were preserved significantly more pronounced than type II fibers fibers (n = 3, p = 0.02). Muscle loss was significantly higher in the control leg (p = 0.012). Protein content also decreased in both legs, but was significantly greater in the control leg (p = 0.04). |
|
| Randomized controlled cross-over trial | no. = 19 | 16 beds ICU in the ICU department of the Le Havre Hospital Group (France) | Single procedure, patients received all interventions with 30min rest in between | Patients act as their own control group after a 30-minute break | Muscle microcirculation by NIRS measurement in the quadriceps femoris vastus lateralis muscle before and after the 10-minute interventions. The relative change in total hemoglobin (THb), oxyhemoglobin and oxymyoglobin (HbO2), and deoxyhemoglobin and deoxymyoglobin (HHb) was measured. | Passive exercise significantly reduced THb by 23% (p = 0.046) and HHb by 27% (p < 0.05). The intervention had no effect on HbO2. Compared to the control group, the intervention had a small effect on the reduction of THb (d = 0.221) and HbO2 (d = 0.319) of the quadriceps vastus lateralis muscle. No effect is evident for HHb (d = 0.117). |
|
| Controlled randomized pilot study | No. = 24 | ICU of the University Hospital of Santa Maria (Brasil) | Passive bed cycling of the lower extremities with 30° upper body elevation in bed during the first week (7 days) in the ICU, 1x/day during 20min at a speed of 20 revolutions/min in addition to standard therapy | Standard therapy with respiratory therapy and motor therapy during 7 days 2x/day 30min (includes the following measures: Vibrocompression, hyperinflation by ventilator and if necessary tracheal suctioning, passive and active-assisted motion therapy of upper and lower extremities in bed) | Quadriceps femoris thickness (QFT) measured by ultrasound within 48h with mechanical ventilation and after 7 days (at the end of the protocol) | Muscle thickness remained unchanged in both groups after implementing the protocol (Control: left QFT p = 0.558; right QFT p = 0.682, Intervention: left QFT p = 0.299; right QFT p = 0.381) |
Presentation of characteristics of included studies based on the Cochrane Checklist [35].
Studies are listed alphabetically in the table, and only those data from the studies that are relevant to answering the research question are presented.
Legend: APACHE II score = Acute Physiology And Chronic Health Evaluation II score (classification system to calculates risk of dying in hospital, the higher the calculated value, the higher the risk of dying in hospital (minimum value = 0; Maximum value = 71) [45]), CG = control group, CPM = continuous passive motion, F/E = flexion and extension, f = female, HbO2 = oxyhemoglobin and oxymyoglobin, HHb = deoxyhemoglobin and deoxymyoglobin, IG = intervention group, ICU = intensive care unit, ICU-AW = intensive care unit-acquired weakness, IFN-γ = interferon γ, IL-6 = interleukin-6, IL-10 = interleukin-10, LE = lower extremity, m = male, M. = musculus, MRC = Medical Research Scale (muscle function testing), NIRS = near-infrared spectroscopy, no. = number of patients, NO = nitric oxide (NO (C-) = NO production of non-stimulated monocytes, NO (C+) = NO production of stimulated monocytes), PF/DE = plantar flexion/dorsal extension, PT = physical therapist, QFT = Quadriceps femoris thickness, RASS = Richmond Agitation Sedation Scale, rep. = repetitions, rev/min = revolutions per minute, SAPS = Simplified Acute Physiology Score (assesses mortality risk of intensive care patients on admission to the ICU, the higher the calculated score, the higher the in-hospital mortality is estimated to be [46]), THb = total hemoglobin, TNF-α = tumor necrosis factor-alpha.
Evaluation of the intervention description.
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Total «+» per study |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| + | + | + | + | - | - | + | + | + | - | - | - |
|
|
| + | + | + | + | - | - | + | + | + | - | - | - |
|
|
| + | + | + | + | - | - | - | + | + | - | - | - |
|
|
| + | + | + | + | + | - | + | + | + | - | - | - |
|
|
| + | + | + | + | - | - | + | + | - | - | - | - |
|
| Total «+» per Item | 5 | 5 | 5 | 5 | 1 | 0 | 4 | 5 | 4 | 0 | 0 | 0 |
Illustration of the assessment of intervention reporting using the TIDieR checklist [29].
Legend: + = sufficiently reported,— = not or not sufficiently reported.
Risk of bias in individual studies.
| Reference | Barbalho (2019) | Franca (2020) | Griffiths (1995) | Medrinal (2018) | Ximenes Carvalho (2019) | Total per item |
|---|---|---|---|---|---|---|
|
| 1 | 1 | 0 | 1 | 1 | 4 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 0 | 1 | 1 | 4 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 0 | 0 | 0 | 1 | 1 | 2 |
|
| 1 | 0 | 0 | 1 | 0 | 2 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 0 | 0 | 1 | 3 |
|
| 0 | 0 | 0 | 0 | 0 | 0 |
|
| 1 | 1 | 0 | 1 | 1 | 4 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 0 | 0 | 0 | 0 | 1 | 1 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 0 | 0 | 1 | 3 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 0 | 1 | 1 | 4 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 1 | 1 | 1 | 1 | 5 |
|
| 1 | 0 | 0 | 1 | 1 | 3 |
|
| 0 | 0 | 0 | 0 | 0 | 0 |
|
| 1 | 0 | 0 | 1 | 0 | 2 |
|
| 0 | 1 | 0 | 1 | 0 | 2 |
|
|
|
|
|
|
|
Presentation of the assessment of the risk of bias of the individual studies using Downs and Black checklist [37].
The studies were sorted alphabetically. The Down and Black checklist was adapted as follows: 0 points (for "no" or "unclear") or 1 point (for "yes") are awarded for each item. For item 4, one point is only awarded if all FITT criteria (F = Frequency, I = Intensity, T = Time, T = Type of exercise) are described [36]. If no information is described for item 19 (assessment of compliance for the intervention), this will be scored as "yes" in the ICU setting and 1 point will be awarded. Items 9 and 26 are scored as "yes" and 1 point if the loss-to-follow-up rate was reported and is < 15%. Finally, item 27 is scored 1 point if a sample-size calculation was performed and 0 points if it was missing. These adjustments result in a total score of 27 points.
Agreement of reviewers.
| A | B | Total | |
|---|---|---|---|
|
| 79 | 26 | 105 |
|
| 8 | 22 | 30 |
|
| 88 | 45 | 135 |
|
| 0.748 | ||
|
| 0.580 | ||
|
| 0.39 | ||
|
| |||
Illustration of the calculation of the investigators’ agreement to assess the methodological quality of the studies with the Downs and Black checklist [37] using the kappa coefficient [39].
Legend: A = Yes, B = No, p0 = measured agreement value of the two estimators, pe = random expected agreement.